Education
About Us
Working with TipRanks
Follow Us
THC Biomed INTL Ltd (THCBF)
OTHER OTC:THCBF
Total Valuation
THC Biomed INTL has a market cap or net worth of $2.42M. The enterprise value is ―.
Market Cap$2.42M
Enterprise Value―
Share Statistics
THC Biomed INTL has 163,937,870 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding163,937,870
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
THC Biomed INTL’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -30.50%.
Return on Equity (ROE)-0.44
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-30.50%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee69.99K
Profits Per Employee-87.60K
Employee Count35
Asset Turnover0.17
Inventory Turnover1.56
Valuation Ratios
The current PE Ratio of THC Biomed INTL is ―. THC Biomed INTL’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value1.32
Price to FCF0.00
Price to Operating Cash Flow-1.77
PEG Ratio―
Income Statement
In the last 12 months, THC Biomed INTL had revenue of 2.45M and earned -3.07M in profits. Earnings per share was -0.02.
Revenue2.45M
Gross Profit-1.03M
Operating Income-2.71M
Pretax Income-3.07M
Net Income-3.07M
EBITDA-1.64M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -503.46K and capital expenditures -232.15K, giving a free cash flow of -735.61K billion.
Operating Cash Flow-503.46K
Free Cash Flow-735.61K
Free Cash Flow per Share>-0.01
Dividends & Yields
THC Biomed INTL pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-480.36
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)197.00
Important Dates
THC Biomed INTL upcoming earnings date is Jun 27, 2024, TBA (Confirmed).
Last Earnings DateMar 29, 2024
Next Earnings DateJun 27, 2024
Ex-Dividend Date―
Financial Position
THC Biomed INTL as a current ratio of 0.63, with Debt / Equity ratio of 64.72%
Current Ratio0.63
Quick Ratio0.22
Debt to Market Cap0.19
Net Debt to EBITDA-0.90
Interest Coverage Ratio-5.41
Taxes
In the past 12 months, THC Biomed INTL has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
THC Biomed INTL EV to EBITDA ratio is -6.51, with an EV/FCF ratio of -5.28.
EV to Sales4.35
EV to EBITDA-6.51
EV to Free Cash Flow-5.28
EV to Operating Cash Flow-5.73
Balance Sheet
THC Biomed INTL has $205.01K in cash and marketable securities with ― in debt, giving a net cash position of -$2.38M billion.
Cash & Marketable Securities$205.01K
Total Debt―
Net Cash-$2.38M
Net Cash Per Share-$0.01
Tangible Book Value Per Share$0.04
Margins
Gross margin is -30.83%, with operating margin of -110.62%, and net profit margin of -125.15%.
Gross Margin-30.83%
Operating Margin-110.62%
Pretax Margin-125.15%
Net Profit Margin-125.15%
EBITDA Margin-66.79%
EBIT Margin-104.69%
Analyst Forecast
The average price target for THC Biomed INTL is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―